본문 바로가기
KERD
논문KCI 등재

백서 치주인대세포에서 Doxycycline의 Mefenamic Acid 병용사용 시 MMP-13 mRNA 발현 억제 효과

Inhibiton of MMP-13 mRNA expression by Doxycycline combination with Mefenamic Acid in the rat Periodontal ligament cells

최득철|김영준|서진희
대한치주과학회 (The Korean Academy Of Periodontology)|2005.03|Journal of Periodontal & Implant Science|제35권 제1호|pp. 99-110

1

조회

0

다운로드

0

인용

0

참고문헌

주제분류치의학

초록

Abstract

It has been focused on the importance of the host inflammatory response in periodontal pathogenesis and progression, treatment has been introduced to control the host response and the method, which diminishes production and activity of MMP by doxycycline, has been used in periodontal field. MMP is a proteolytic enzyme which plays a major role in tissue destruction and MMP-1 is secreted in the periodontally healthy tissue, while MMP-8, 9, 13, etc in the inflammatory state. Among these, MMP-13 has been discovered lately and reported to degrade primarily type Ⅱ collagen. Periodontal ligament (PDL) cell plays a role in destruction of periodontal tissue. This study was to evaluate the effect of doxycycline and mefenamic acid, non-steroidal anti-inflammatory drug on MMP-13 mRNA expression in the rat PDL cell. Doxycycline concentration of 1~100 ㎍/㎖ was added rat PDL cell and cell activity was measured by MTT assay at day 1 and 3. MMP-13 gene expression was evaluated by RT-PCR after PDL cells were pre-treated for 1 hour with doxycycline (50 ㎍/㎖) alone or with mefenamic acid (10-6 M), then added IL-1β (1.0 ng/㎖) and incubated for 16 -18 hours. The results are as follows: 1. Cell activity decreased significantly at 24 and 72 hours in 100 ㎍/㎖ (p<0.05). 2. Level of MMP-13 mRNA was in 202% increase by IL-1β and in pre-treating doxycycline group, expression of IL-1β induced MMP-13 mRNA was inhibited by 31% than IL-1β treated only. 3. Mefenamic acid did not inhibit on the expression of IL-1β induced MMP-13 mRNA, while mefenamic acid in combination with doxycycline inhibited the expression by 41% compared to only IL-1β stimulation. These results suggest that doxycycline synergistically inhibit the expression of IL-1β induced MMP-13 mRNA in combination with mefenamic acid.

참고문헌 (37)

  1. "Periodontal diseases:patho- genesis", 1, pp.821~878 (1996)
  2. "Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis.A review", 31, pp.697~707 (2004)
  3. "Role of matrix metalloproteinases in human periodontal diseases", 64, pp.474~484 (1993)
  4. "Matrix metalloprotenases.A review", 4, pp.197~250 (1993)
  5. "Matrix metalloprotinases and their inhibition in periodontal treatment", 3, pp.85~96 (1996)
  6. "Collagenolytic activity of gingivae of man", 209, pp.728~729 (1966)
  7. "Low-dose doxycycline therapy:effect on gingival and crevicular fluid collagenase activity in humans", 25, pp.321~330 (1990)
  8. "A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragment and bone-type collagenase in gingival crevicular fluid during adult periodontitis", 4, pp.310~319 (1997)
  9. "Molecular cloning and expression of collagenase-3 a novel human matrix metalloproteinse produced by breast carcinomas", pp.16766~16773 (1994), Lopez-Ortin C
  10. "Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases", pp.188~195 (2003)
  11. "테트라사이클린계 약물이 치은섬유아세포내 MMP-13의 활성도에 미치는 영향", 29, pp.677~691 (1999)
  12. "Doxycycline inhibits neutrophil(PMN)-type matrix metalloproteinases in human adult periodontitis gingiva", 22, pp.100~109 (1995)
  13. "Specificity of inhibition of matrix metalloproteinase activity by doxycycline:relationship to structure of the enzyme", 42, pp.1140~1146 (1999)
  14. "Tetracycline suppresses metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen", pp.927~938 (1992)
  15. "Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinases inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug", 75, pp.453~463 (2004)
  16. "Effects of TNFalpha and prostaglandin E2 on the expression of MMPs in human periodontal ligament fibroblasts", 37, pp.167~76 (2002)
  17. "Mitogenic chemotactic and synthetic responses of rat periodontal fibroblastic cells to polypeptide growth factors in vitro", 63, pp.515~525 (1992)
  18. "Host modulation with tetracyclines and their chemically-modified analogs", 2, pp.80~90 (1992)
  19. "Tetracyclines inhibit connective tissue break down by multiple non-antimicrobial mechanisms", 12, pp.12~26 (1998)
  20. "as adjunctive management in adult periodontitis Effects on subgingival bacterial population dynamics", pp.32~39 (1998)
  21. "Long-term treatment with subantimicrobial dose doxycycline exerts no antibacterial effect on the subgingival microflora associated with adult periodontitis", 71, pp.1465~1471 (2000)
  22. "Effects of sub-antimicrobial dose doxycycline in the treatment of moderate acne", 139, pp.459~464 (2003)
  23. "Discoordinate expression of stromelysin and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression", pp.17238~17245 (1990)
  24. "Differential regulation of MMP-13 by chemical modified tetracycline in osteoblasts", 6, pp.39~46 (2004)
  25. "Regulation of matrix metalloproteinase production by cytokines pharmacological agents and periodontal pathogens in human periodontal ligament fibroblast cultures", pp.196~203 (2002)
  26. "CMT", tenidap treatment inhibits TMJ destruction in adjuvant arthritis(AA)rats, 1994, pp.732, 140~151
  27. "Effective treatment for cicatricial pemphigoid using a novel combination therapy", 19, pp.584~592 (2001)
  28. "Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial actions", 12, pp.12~26 (1998)
  29. "Scavenging of hypochlorose acid by tetracycline a possible antioxidant action of rifampicin and tetracycline", pp.775~778 (1988)
  30. "Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase", 8, pp.1247~1253 (1993)
  31. "How do tetracycline work?", pp.149~151 (1998)
  32. "Inhibition of epithelial cell matrix metalloproteinases by tetracyclines", 28, pp.379~385 (1993)
  33. "expression is induced in oral mucosal epithelium during chronic inflammation", pp.1489~3 13 1499 (1998), Lopez-Otin C Saarialho-Kere U
  34. "Evaluation of Periostat for patient management", 20, pp.451~456 (1999)
  35. "The pharmacological basis of therapeutics", moli(ff), pp.1123~1153 (1996), McGraw-Hill
  36. "Concentration of 3 tetracyclines in plasma", pp.53~60 (2000)
  37. "Concentration of 3 tetracyclines in plasma", pp.53~60 (2000)

관련 논문AI추천

백서 치주인대세포에서 Doxycycline에 의한 mRANKL 발현 억제김영준, 조관표, 최득철대한치주과학회 · Journal of Periodontal & Implant Science2006 · 제36권 제2호백서 치주인대세포에서의 MMP-13 mRNA에 대한 MAP kinase의 역할김영준, 정찬길, 정현주, 최득철대한치주과학회 · Journal of Periodontal & Implant Science2006 · 제36권 제1호다양한 NSAID가 인간 치주인대세포의 prostaglandin 합성 및 세포 형태에 미치는 효과에 대한 연구김혁수, 박준우, 심혜영, 장영일, 채창훈대한구강악안면외과학회 · 대한구강악안면외과학회지2007 · 제33권 제5호Prevotella intermedia의 세균내독소가 치은섬유아세포와 치주인대세포에서의 matrix metalloproteinase 및 tissue inhibitor of metalloproteinase의 발현에 미치는 영향김성조, 김종관, 이주연, 최은영, 최인순, 최점일대한치주과학회 · Journal of Periodontal & Implant Science2005 · 제35권 제1호Rat periodontal ligament cell에서의 RANKL mRNA의 발현김영준, 김옥수, 김현수, 정현주대한치주과학회 · Journal of Periodontal & Implant Science2004 · 제34권 제2호쥐치아 치근면의 치주인대세포의 활성도를 평가하는 방법으로 MTT검색법의 적절성에 대한 조직학적인 검증김진, 김의성, 김현기, 이승종, 최인복대한치과보존학회 · Restorative Dentistry and Endodontics2003 · 제28권 제5호

이 간행물의 다른 논문 (20건)

실험적 동맥경화증에서 Porphyromonas gingivalis 열충격단백-항원결정부위-특이성 T-세포주의 SCID mice내로의 주입효과에 대한 연구Joseph Witztum, 최점일pp. 1-8괴화 추출물이 대식세포에서의 nitric oxide와 interleukin-6의 생성에 미치는 영향김성조, 김종관, 최점일, 이지은, 이주연pp. 9-20Prevotella intermedia의 세균내독소가 치은섬유아세포와 치주인대세포에서의 matrix metalloproteinase 및 tissue inhibitor of metalloproteinase의 발현에 미치는 영향최인순, 이주연, 최점일, 김성조, 김종관, 최은영pp. 21-30임플란트주위염시 Porphyromonas gingivalis 섬모유전형의 출현율정종혁, 권영혁, 박준봉, 신승일, 허익pp. 31-42유지치주치료기간과 치은연하세균 출현율의 관계권영혁, 허익, 김진철, 정종혁, 박준봉pp. 43-52
원문 보기